Clinical management of severe infections caused by carbapenem-resistant Gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations
Clinical management of severe infections caused by carbapenem-resistant Gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations
(2022)
Clinical management of severe infections caused by carbapenem-resistant Gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations
Optimal treatment of carbapenem-resistant Gram-negative (CR-GNB) infections is uncertain due to the lack of good-quality evidence and the limited effectiveness of available antibiotics. The aim of this survey was to investigate clinicians' prescribing strategies for treating CR-GNB infections worldwide.
Note:
Epub 2021 May 8
Id prodotto:
121069
Handle IRIS:
11562/1043462
ultima modifica:
14 novembre 2022
Citazione bibliografica:
Carrara, Elena; Savoldi, Alessia; Piddock, Laura Jv; Franceschi, Francois; Ellis, Sally; Sharland, Mike; John Brink, Adrian; Harris, Patrick Na; Levy-Hara, Gabriel; Rohit, Anusha; Tsioutis, Constantinos; Zayyad, Hiba; Giske, Christian; Chiamenti, Margherita; Bragantini, Damiano; Righi, Elda; Gorska, Anna; Tacconelli, Evelina,
Clinical management of severe infections caused by carbapenem-resistant Gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations«Clinical Microbiology and Infection»
, vol. 28
, n. 1
, 2022
, pp. 66-72